Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 342

1.

Diffusion-time dependence of diffusional kurtosis in the mouse brain.

Aggarwal M, Smith MD, Calabresi PA.

Magn Reson Med. 2020 Feb 5. doi: 10.1002/mrm.28189. [Epub ahead of print]

PMID:
32022313
2.

Retinal pathology occurs in stiff-person syndrome.

Lambe J, Rothman A, Prince J, Saidha S, Calabresi PA, Newsome SD.

Neurology. 2020 Jan 10. pii: 10.1212/WNL.0000000000008943. doi: 10.1212/WNL.0000000000008943. [Epub ahead of print]

PMID:
31924684
3.

Fully Convolutional Boundary Regression for Retina OCT Segmentation.

He Y, Carass A, Liu Y, Jedynak BM, Solomon SD, Saidha S, Calabresi PA, Prince JL.

Med Image Comput Comput Assist Interv. 2019 Oct;11764:120-128. doi: 10.1007/978-3-030-32239-7_14. Epub 2019 Oct 10.

4.

Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis.

Sabatino JJ Jr, Wilson MR, Calabresi PA, Hauser SL, Schneck JP, Zamvil SS.

Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25800-25807. doi: 10.1073/pnas.1915309116. Epub 2019 Nov 20.

5.

Immune cell modulation of oligodendrocyte lineage cells.

Harrington EP, Bergles DE, Calabresi PA.

Neurosci Lett. 2020 Jan 10;715:134601. doi: 10.1016/j.neulet.2019.134601. Epub 2019 Nov 3. Review.

PMID:
31693930
6.

Deep learning based topology guaranteed surface and MME segmentation of multiple sclerosis subjects from retinal OCT.

He Y, Carass A, Liu Y, Jedynak BM, Solomon SD, Saidha S, Calabresi PA, Prince JL.

Biomed Opt Express. 2019 Sep 12;10(10):5042-5058. doi: 10.1364/BOE.10.005042. eCollection 2019 Oct 1.

7.

Monitoring diffuse injury during disease progression in experimental autoimmune encephalomyelitis with on resonance variable delay multiple pulse (onVDMP) CEST MRI.

Thomas AM, Xu J, Calabresi PA, van Zijl PCM, Bulte JWM.

Neuroimage. 2020 Jan 1;204:116245. doi: 10.1016/j.neuroimage.2019.116245. Epub 2019 Oct 9.

8.

NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity.

Gharagozloo M, Mahmoud S, Simard C, Yamamoto K, Bobbala D, Ilangumaran S, Smith MD, Lamontagne A, Jarjoura S, Denault JB, Blais V, Gendron L, Vilariño-Güell C, Sadovnick AD, Ting JP, Calabresi PA, Amrani A, Gris D.

PLoS Biol. 2019 Sep 16;17(9):e3000451. doi: 10.1371/journal.pbio.3000451. eCollection 2019 Sep.

9.

Quetiapine has an additive effect to triiodothyronine in inducing differentiation of oligodendrocyte precursor cells through induction of cholesterol biosynthesis.

Gonzalez Cardona J, Smith MD, Wang J, Kirby L, Schott JT, Davidson T, Karnell JL, Whartenby KA, Calabresi PA.

PLoS One. 2019 Sep 6;14(9):e0221747. doi: 10.1371/journal.pone.0221747. eCollection 2019.

10.

Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination.

Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J, Strasburger H, Herbst L, Alexis M, Karnell J, Davidson T, Dutta R, Goverman J, Bergles D, Calabresi PA.

Nat Commun. 2019 Aug 29;10(1):3887. doi: 10.1038/s41467-019-11638-3.

11.

Glutamine antagonism attenuates physical and cognitive deficits in a model of MS.

Hollinger KR, Smith MD, Kirby LA, Prchalova E, Alt J, Rais R, Calabresi PA, Slusher BS.

Neurol Neuroimmunol Neuroinflamm. 2019 Aug 29;6(6). pii: e609. doi: 10.1212/NXI.0000000000000609. Print 2019 Nov.

12.

The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States.

Beecham AH, Amezcua L, Chinea A, Manrique CP, Rubi C, Isobe N, Lund BT, Santaniello A, Beecham GW, Burchard EG, Comabella M, Patsopoulos N, Fitzgerald K, Calabresi PA, De Jager P, Conti DV, Delgado SR, Oksenberg JR, McCauley JL.

Mult Scler. 2019 Aug 1:1352458519863764. doi: 10.1177/1352458519863764. [Epub ahead of print]

PMID:
31368393
13.

Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis.

Jin J, Smith MD, Kersbergen CJ, Kam TI, Viswanathan M, Martin K, Dawson TM, Dawson VL, Zack DJ, Whartenby K, Calabresi PA.

Acta Neuropathol Commun. 2019 Jul 31;7(1):125. doi: 10.1186/s40478-019-0767-6.

14.

Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning.

Sotirchos ES, Filippatou A, Fitzgerald KC, Salama S, Pardo S, Wang J, Ogbuokiri E, Cowley NJ, Pellegrini N, Murphy OC, Mealy MA, Prince JL, Levy M, Calabresi PA, Saidha S.

Mult Scler. 2019 Jul 31:1352458519864928. doi: 10.1177/1352458519864928. [Epub ahead of print]

PMID:
31364464
15.

DeepHarmony: A deep learning approach to contrast harmonization across scanner changes.

Dewey BE, Zhao C, Reinhold JC, Carass A, Fitzgerald KC, Sotirchos ES, Saidha S, Oh J, Pham DL, Calabresi PA, van Zijl PCM, Prince JL.

Magn Reson Imaging. 2019 Dec;64:160-170. doi: 10.1016/j.mri.2019.05.041. Epub 2019 Jul 10.

PMID:
31301354
16.

Early complement genes are associated with visual system degeneration in multiple sclerosis.

Fitzgerald KC, Kim K, Smith MD, Aston SA, Fioravante N, Rothman AM, Krieger S, Cofield SS, Kimbrough DJ, Bhargava P, Saidha S, Whartenby KA, Green AJ, Mowry EM, Cutter GR, Lublin FD, Baranzini SE, De Jager PL, Calabresi PA.

Brain. 2019 Sep 1;142(9):2722-2736. doi: 10.1093/brain/awz188.

PMID:
31289819
17.

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.

Cadavid D, Mellion M, Hupperts R, Edwards KR, Calabresi PA, Drulović J, Giovannoni G, Hartung HP, Arnold DL, Fisher E, Rudick R, Mi S, Chai Y, Li J, Zhang Y, Cheng W, Xu L, Zhu B, Green SM, Chang I, Deykin A, Sheikh SI; SYNERGY study investigators.

Lancet Neurol. 2019 Sep;18(9):845-856. doi: 10.1016/S1474-4422(19)30137-1. Epub 2019 Jul 5.

PMID:
31285147
18.

Applications of a deep learning method for anti-aliasing and super-resolution in MRI.

Zhao C, Shao M, Carass A, Li H, Dewey BE, Ellingsen LM, Woo J, Guttman MA, Blitz AM, Stone M, Calabresi PA, Halperin H, Prince JL.

Magn Reson Imaging. 2019 Dec;64:132-141. doi: 10.1016/j.mri.2019.05.038. Epub 2019 Jun 24.

PMID:
31247254
19.

Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures.

Murphy OC, Kwakyi O, Iftikhar M, Zafar S, Lambe J, Pellegrini N, Sotirchos ES, Gonzalez-Caldito N, Ogbuokiri E, Filippatou A, Risher H, Cowley N, Feldman S, Fioravante N, Frohman EM, Frohman TC, Balcer LJ, Prince JL, Channa R, Calabresi PA, Saidha S.

Mult Scler. 2019 May 16:1352458519845116. doi: 10.1177/1352458519845116. [Epub ahead of print]

PMID:
31094280
20.

Longitudinal assessment of hand function in individuals with multiple sclerosis.

Newsome SD, von Geldern G, Shou H, Baynes M, Marasigan RER, Calabresi PA, Zackowski KM.

Mult Scler Relat Disord. 2019 Jul;32:107-113. doi: 10.1016/j.msard.2019.04.035. Epub 2019 May 6.

PMID:
31085489
21.

Macular Ganglion Cell and Inner Plexiform Layer Thickness Is More Strongly Associated With Visual Function in Multiple Sclerosis Than Bruch Membrane Opening-Minimum Rim Width or Peripapillary Retinal Nerve Fiber Layer Thicknesses.

Nguyen J, Rothman A, Gonzalez N, Avornu A, Ogbuokiri E, Balcer LJ, Galetta SL, Frohman EM, Frohman T, Crainiceanu C, Calabresi PA, Saidha S.

J Neuroophthalmol. 2019 Dec;39(4):444-450. doi: 10.1097/WNO.0000000000000768.

PMID:
30921169
22.

Quantitative vibratory sensation measurement is related to sensory cortical thickness in MS.

Fritz NE, Eloyan A, Glaister J, Dewey BE, Al-Louzi O, Costello MG, Chen M, Prince JL, Calabresi PA, Zackowski KM.

Ann Clin Transl Neurol. 2019 Feb 19;6(3):586-595. doi: 10.1002/acn3.734. eCollection 2019 Mar.

23.

Layer boundary evolution method for macular OCT layer segmentation.

Liu Y, Carass A, He Y, Antony BJ, Filippatou A, Saidha S, Solomon SD, Calabresi PA, Prince JL.

Biomed Opt Express. 2019 Feb 4;10(3):1064-1080. doi: 10.1364/BOE.10.001064. eCollection 2019 Mar 1.

24.

Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study.

Nolan-Kenney RC, Liu M, Akhand O, Calabresi PA, Paul F, Petzold A, Balk L, Brandt AU, Martínez-Lapiscina EH, Saidha S, Villoslada P, Al-Hassan AA, Behbehani R, Frohman EM, Frohman T, Havla J, Hemmer B, Jiang H, Knier B, Korn T, Leocani L, Papadopoulou A, Pisa M, Zimmermann H, Galetta SL, Balcer LJ; International Multiple Sclerosis Visual System Consortium.

Ann Neurol. 2019 May;85(5):618-629. doi: 10.1002/ana.25462. Epub 2019 Apr 10.

PMID:
30851125
25.

Retinal measurements predict 10-year disability in multiple sclerosis.

Rothman A, Murphy OC, Fitzgerald KC, Button J, Gordon-Lipkin E, Ratchford JN, Newsome SD, Mowry EM, Sotirchos ES, Syc-Mazurek SB, Nguyen J, Caldito NG, Balcer LJ, Frohman EM, Frohman TC, Reich DS, Crainiceanu C, Saidha S, Calabresi PA.

Ann Clin Transl Neurol. 2019 Jan 19;6(2):222-232. doi: 10.1002/acn3.674. eCollection 2019 Feb.

26.

Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.

Oh J, Ontaneda D, Azevedo C, Klawiter EC, Absinta M, Arnold DL, Bakshi R, Calabresi PA, Crainiceanu C, Dewey B, Freeman L, Gauthier S, Henry R, Inglese M, Kolind S, Li DKB, Mainero C, Menon RS, Nair G, Narayanan S, Nelson F, Pelletier D, Rauscher A, Rooney W, Sati P, Schwartz D, Shinohara RT, Tagge I, Traboulsee A, Wang Y, Yoo Y, Yousry T, Zhang Y, Sicotte NL, Reich DS; North American Imaging in Multiple Sclerosis Cooperative.

Neurology. 2019 Mar 12;92(11):519-533. doi: 10.1212/WNL.0000000000007099. Epub 2019 Feb 20. Review. Erratum in: Neurology. 2019 Jul 2;93(1):46.

PMID:
30787160
27.

Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement.

Bhargava P, Wicken C, Smith MD, Strowd RE, Cortese I, Reich DS, Calabresi PA, Mowry EM.

Mult Scler Relat Disord. 2019 May;30:136-140. doi: 10.1016/j.msard.2019.02.013. Epub 2019 Feb 11.

PMID:
30771580
28.

Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.

Sotirchos ES, Gonzalez-Caldito N, Dewey BE, Fitzgerald KC, Glaister J, Filippatou A, Ogbuokiri E, Feldman S, Kwakyi O, Risher H, Crainiceanu C, Pham DL, Van Zijl PC, Mowry EM, Reich DS, Prince JL, Calabresi PA, Saidha S.

Mult Scler. 2019 Feb 11:1352458519826364. doi: 10.1177/1352458519826364. [Epub ahead of print]

PMID:
30741108
29.

Retinal layer parcellation of optical coherence tomography images: Data resource for multiple sclerosis and healthy controls.

He Y, Carass A, Solomon SD, Saidha S, Calabresi PA, Prince JL.

Data Brief. 2018 Dec 28;22:601-604. doi: 10.1016/j.dib.2018.12.073. eCollection 2019 Feb.

30.

Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes.

Bhargava P, Fitzgerald KC, Venkata SLV, Smith MD, Kornberg MD, Mowry EM, Haughey NJ, Calabresi PA.

Ann Clin Transl Neurol. 2018 Oct 30;6(1):33-45. doi: 10.1002/acn3.676. eCollection 2019 Jan.

31.

Multisite reliability and repeatability of an advanced brain MRI protocol.

Schwartz DL, Tagge I, Powers K, Ahn S, Bakshi R, Calabresi PA, Todd Constable R, Grinstead J, Henry RG, Nair G, Papinutto N, Pelletier D, Shinohara R, Oh J, Reich DS, Sicotte NL, Rooney WD; NAIMS Cooperative.

J Magn Reson Imaging. 2019 Sep;50(3):878-888. doi: 10.1002/jmri.26652. Epub 2019 Jan 16.

PMID:
30652391
32.

PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R).

Horti AG, Naik R, Foss CA, Minn I, Misheneva V, Du Y, Wang Y, Mathews WB, Wu Y, Hall A, LaCourse C, Ahn HH, Nam H, Lesniak WG, Valentine H, Pletnikova O, Troncoso JC, Smith MD, Calabresi PA, Savonenko AV, Dannals RF, Pletnikov MV, Pomper MG.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1686-1691. doi: 10.1073/pnas.1812155116. Epub 2019 Jan 11.

33.

Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness.

Filippatou A, Shoemaker T, Esch M, Qutab M, Gonzalez-Caldito N, Prince JL, Mowry EM, Calabresi PA, Saidha S, Sotirchos ES.

Mult Scler. 2019 Dec;25(14):1878-1887. doi: 10.1177/1352458518815597. Epub 2018 Dec 3.

PMID:
30507269
34.

Alu insertion variants alter mRNA splicing.

Payer LM, Steranka JP, Ardeljan D, Walker J, Fitzgerald KC, Calabresi PA, Cooper TA, Burns KH.

Nucleic Acids Res. 2019 Jan 10;47(1):421-431. doi: 10.1093/nar/gky1086.

35.

The International Multiple Sclerosis Visual System Consortium: Advancing Visual System Research in Multiple Sclerosis.

Balcer LJ, Balk LJ, Brandt AU, Calabresi PA, Martinez-Lapiscina EH, Nolan RC, Paul F, Petzold A, Saidha S.

J Neuroophthalmol. 2018 Dec;38(4):494-501. doi: 10.1097/WNO.0000000000000732.

PMID:
30418332
36.

Microvascular blood flow velocities measured with a retinal function imager: inter-eye correlations in healthy controls and an exploration in multiple sclerosis.

Wang L, Kwakyi O, Nguyen J, Ogbuokiri E, Murphy O, Caldito NG, Balcer L, Frohman E, Frohman T, Calabresi PA, Saidha S.

Eye Vis (Lond). 2018 Nov 2;5:29. doi: 10.1186/s40662-018-0123-0. eCollection 2018.

37.

Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior.

Linville RM, DeStefano JG, Sklar MB, Xu Z, Farrell AM, Bogorad MI, Chu C, Walczak P, Cheng L, Mahairaki V, Whartenby KA, Calabresi PA, Searson PC.

Biomaterials. 2019 Jan;190-191:24-37. doi: 10.1016/j.biomaterials.2018.10.023. Epub 2018 Oct 25.

38.

Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Caldito NG, Saidha S, Sotirchos ES, Dewey BE, Cowley NJ, Glaister J, Fitzgerald KC, Al-Louzi O, Nguyen J, Rothman A, Ogbuokiri E, Fioravante N, Feldman S, Kwakyi O, Risher H, Kimbrough D, Frohman TC, Frohman E, Balcer L, Crainiceanu C, Van Zijl PCM, Mowry EM, Reich DS, Oh J, Pham DL, Prince J, Calabresi PA.

Brain. 2018 Nov 1;141(11):3115-3129. doi: 10.1093/brain/awy245.

39.

Emerging Applications of Optical Coherence Tomography Angiography (OCTA) in neurological research.

Wang L, Murphy O, Caldito NG, Calabresi PA, Saidha S.

Eye Vis (Lond). 2018 May 12;5:11. doi: 10.1186/s40662-018-0104-3. eCollection 2018. Review.

40.

Dice Overlap Measures for Objects of Unknown Number: Application to Lesion Segmentation.

Oguz I, Carass A, Pham DL, Roy S, Subbana N, Calabresi PA, Yushkevich PA, Shinohara RT, Prince JL.

Brainlesion. 2018;10670:3-14. doi: 10.1007/978-3-319-75238-9_1. Epub 2018 Feb 17.

41.

Joint Intensity Fusion Image Synthesis Applied to Multiple Sclerosis Lesion Segmentation.

Fleishman GM, Valcarcel A, Pham DL, Roy S, Calabresi PA, Yushkevich P, Shinohara RT, Oguz I.

Brainlesion. 2018;10670:43-54. Epub 2018 Feb 17.

42.

Visual Pathway Measures are Associated with Neuropsychological Function in Multiple Sclerosis.

Nguyen J, Rothman A, Fitzgerald K, Whetstone A, Syc-Mazurek S, Aquino J, Balcer LJ, Frohman EM, Frohman TC, Crainiceanu C, Beier M, Newsome SD, Calabresi PA, Saidha S.

Curr Eye Res. 2018 Jul;43(7):941-948. doi: 10.1080/02713683.2018.1459730. Epub 2018 May 1.

43.

Multi-layer Fast Level Set Segmentation for Macular OCT.

Liu Y, Carass A, Solomon SD, Saidha S, Calabresi PA, Prince JL.

Proc IEEE Int Symp Biomed Imaging. 2018 Apr;2018:1445-1448. doi: 10.1109/ISBI.2018.8363844. Epub 2018 May 24.

44.

Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.

Kornberg MD, Bhargava P, Kim PM, Putluri V, Snowman AM, Putluri N, Calabresi PA, Snyder SH.

Science. 2018 Apr 27;360(6387):449-453. doi: 10.1126/science.aan4665. Epub 2018 Mar 29.

45.

MIMoSA: An Automated Method for Intermodal Segmentation Analysis of Multiple Sclerosis Brain Lesions.

Valcarcel AM, Linn KA, Vandekar SN, Satterthwaite TD, Muschelli J, Calabresi PA, Pham DL, Martin ML, Shinohara RT.

J Neuroimaging. 2018 Jul;28(4):389-398. doi: 10.1111/jon.12506. Epub 2018 Mar 8.

46.

Central vein sign in multiple sclerosis: Ready for front and center?

Miller AE, Calabresi PA.

Neurology. 2018 Apr 3;90(14):631-632. doi: 10.1212/WNL.0000000000005241. Epub 2018 Mar 7. No abstract available.

PMID:
29514945
47.

An Automated Statistical Technique for Counting Distinct Multiple Sclerosis Lesions.

Dworkin JD, Linn KA, Oguz I, Fleishman GM, Bakshi R, Nair G, Calabresi PA, Henry RG, Oh J, Papinutto N, Pelletier D, Rooney W, Stern W, Sicotte NL, Reich DS, Shinohara RT; North American Imaging in Multiple Sclerosis Cooperative.

AJNR Am J Neuroradiol. 2018 Apr;39(4):626-633. doi: 10.3174/ajnr.A5556. Epub 2018 Feb 22.

48.

Bryostatin-1 alleviates experimental multiple sclerosis.

Kornberg MD, Smith MD, Shirazi HA, Calabresi PA, Snyder SH, Kim PM.

Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2186-2191. doi: 10.1073/pnas.1719902115. Epub 2018 Feb 12.

49.

Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis.

Nolan RC, Galetta SL, Frohman TC, Frohman EM, Calabresi PA, Castrillo-Viguera C, Cadavid D, Balcer LJ.

J Neuroophthalmol. 2018 Dec;38(4):451-458. doi: 10.1097/WNO.0000000000000629.

PMID:
29384802
50.

Inter-scanner Variation Independent Descriptors for Constrained Diffeomorphic Demons Registration of Retina OCT.

Reaungamornrat S, Carass A, He Y, Saidha S, Calabresi PA, Prince JL.

Proc SPIE Int Soc Opt Eng. 2018 Feb;10574. pii: 105741B. doi: 10.1117/12.2293790. Epub 2018 Mar 2.

Supplemental Content

Loading ...
Support Center